本文選題：腦心動脈粥樣硬化　切入點(diǎn)：易患因素　出處：《遼寧中醫(yī)雜志》2017年02期

【摘要】：目的:探討腦心動脈粥樣硬化的中醫(yī)證型間易患因素的關(guān)系和血脂與本病的關(guān)系及腦心通膠囊的干預(yù)研究,為中醫(yī)診斷和辨證施治提供客觀依據(jù),以更好地服務(wù)于臨床。方法:400例患者以EXCEL表格的形式錄入患者信息,采用問卷調(diào)查的方式,對患者的姓名、性別、年齡、身高、體重等一般資料進(jìn)行記錄,對心系證候證候、全身證候、飲食口味相關(guān)證候、舌、脈象等信息進(jìn)行采集;對其中氣虛血瘀證患者加服腦心通膠囊治療,療程4周,觀察癥狀積分及血脂變化。結(jié)果:以計(jì)數(shù)資料進(jìn)行統(tǒng)計(jì)。結(jié)果有效病例392例,腦心動脈粥樣硬化的中醫(yī)證型分布情況,痰瘀互結(jié)型、肝腎陰虛型、氣虛血瘀型、脾虛濕盛型(按頻次統(tǒng)計(jì)由多到少排列)。各證型平均年齡組間沒有顯著差異(P0.05)。痰瘀互結(jié)組與氣虛血瘀組組間比較有顯著差異(P0.05);其余各組間比較均無顯著差異(P0.05)。各證型血脂組間兩兩比較,無顯著差異(P0.05)。用步長腦心通膠囊干預(yù)4周后,氣虛血瘀型腦心動脈粥樣硬化患者癥狀明顯改善,差異有統(tǒng)計(jì)學(xué)意義(P0.05);血脂水平明顯降低,比較有統(tǒng)計(jì)學(xué)意義(P0.05)。結(jié)論:中醫(yī)藥如能干預(yù)腦心動脈粥樣硬化效果會十分理想,但需要建立統(tǒng)一的辨證論治標(biāo)準(zhǔn)體系,規(guī)范中醫(yī)治療。
[Abstract]:Objective: to explore the relationship between the risk factors of TCM syndrome type of cerebral heart atherosclerosis and the relationship between blood lipids and this disease and the intervention of Naoxintong capsule, so as to provide an objective basis for the diagnosis and treatment of TCM syndrome differentiation. Methods four hundred cases of patients were recorded in the form of EXCEL, and the general data of name, sex, age, height, weight were recorded by questionnaire, and the syndromes and syndromes of heart system were recorded. The whole body syndrome, diet taste related syndromes, tongue, pulse and other information were collected. The patients with Qi deficiency and blood stasis syndrome were treated with Naoxintong capsule for 4 weeks. Results: according to the count data, 392 effective cases, the distribution of TCM syndromes, phlegm and blood stasis, liver and kidney yin deficiency, qi deficiency and blood stasis, were observed. There was no significant difference among the average age groups of each syndrome type. There was a significant difference between phlegm and blood stasis group and Qi deficiency and blood stasis group (P 0.05), but there was no significant difference between the other groups (P 0.05). Comparison between two groups of syndromic blood lipids, After 4 weeks of intervention with Buchang Naoxintong capsule, the symptoms of patients with cerebral heart artery atherosclerosis with Qi deficiency and blood stasis were obviously improved, the difference was statistically significant (P 0.05), and the level of blood lipid was obviously decreased. Conclusion: the effect of Chinese medicine on cerebral and cardiac atherosclerosis is very ideal, but it is necessary to establish a unified standard system of syndrome differentiation and treatment and standardize the treatment of traditional Chinese medicine.
【作者單位】： 邢臺醫(yī)學(xué)高等�？茖W(xué)校;
【分類號】：R259

【相似文獻(xiàn)】

相關(guān)期刊論文 前10條

1 王彤;陳旗;王紅星;單春雷;王翔;朱奕;;腦心通膠囊治療缺血性腦血管病臨床療效[J];江蘇醫(yī)藥;2006年02期

2 車法亮;裴全森;;腦心通膠囊治療腦梗死38例臨床觀察[J];中國中醫(yī)急癥;2006年05期

3 林梅瑟;張炳才;張?jiān)葡?李玉梅;;腦心通膠囊治療冠心病無癥狀心肌缺血[J];中西醫(yī)結(jié)合心腦血管病雜志;2006年07期

4 鄧紹林;鄒振宇;李靜;;腦心通膠囊治療老年短暫性腦缺血發(fā)作臨床觀察[J];中西醫(yī)結(jié)合心腦血管病雜志;2007年02期

5 余鋒;趙煥東;;腦心通膠囊治療短暫性腦缺血發(fā)作136例臨床分析[J];中西醫(yī)結(jié)合心腦血管病雜志;2007年09期

6 余鋒;趙煥東;;腦心通膠囊治療短暫性腦缺血發(fā)作136例臨床分析[J];吉林醫(yī)學(xué);2007年09期

7 賈連旺;杜永遠(yuǎn);胡鷹;孟仲蔚;;腦心通膠囊對冠心病無癥狀心肌缺血病人血管內(nèi)皮依賴性舒張功能的影響[J];中西醫(yī)結(jié)合心腦血管病雜志;2007年10期

8 牛銳;;腦心通膠囊治療短暫性腦缺血發(fā)作的臨床研究[J];河南中醫(yī)學(xué)院學(xué)報(bào);2008年04期

9 姜月峰;;腦心通膠囊對短暫性腦缺血發(fā)作的療效及對血液流變學(xué)的影響[J];實(shí)用心腦肺血管病雜志;2009年05期

10 蔣紹軍;趙曉紅;;腦心通膠囊對缺血性腦卒中患者胰島素抵抗和預(yù)后的影響[J];實(shí)用心腦肺血管病雜志;2009年12期

相關(guān)會議論文 前1條

1 王志強(qiáng);;腦心通膠囊治療2型糖尿病合并冠心病65例臨床觀察[A];第十次全國中醫(yī)糖尿病大會論文集[C];2007年

相關(guān)重要報(bào)紙文章 前1條

1 吉林省鎮(zhèn)賚縣中醫(yī)院內(nèi)科 李玉成;腦心通膠囊治療心腦血管病的療效觀察[N];醫(yī)藥經(jīng)濟(jì)報(bào);2011年

相關(guān)碩士學(xué)位論文 前1條

1 呂欣芳;腦心通膠囊對冠心病心絞痛氣虛血瘀型患者血管內(nèi)皮功能影響的臨床觀察[D];成都中醫(yī)藥大學(xué);2013年

，

本文編號：1688441